Trials / Completed
CompletedNCT00000267
Risperidone Treatment in Dually-Diagnosed Individuals - 2
Risperidone Treatment in Dually-Diagnosed Individuals
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of risperidone for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risperidone |
Timeline
- Completion
- 2001-12-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000267. Inclusion in this directory is not an endorsement.